[Effect of live tularemia vaccine on the counter-suppression of lymphocytes and the end results of the combined treatment of endometrial cancer].
Starting from stage I-II, patients with endometrial tumors (ET) revealed a significant decline (p < 0.05) in counter-suppression lymphocytes as compared to healthy subjects of the same age. The correlation was particularly marked in cases of stage III-IV tumors (p < 0.01).
Adamian
R T
RT
V.A. Fanarjyan Center for Cancer Research, Yerevan.
Markosian
K M
KM
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism*; D008875:Middle Aged; D009367:Neoplasm Staging; D016896:Treatment Outcome; D014406:Tularemia / Q000276:immunology*; D014594:Uterine Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy*
D001428:Bacterial Vaccines; D019496:Cancer Vaccines